These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 29915703)
1. Synergistic and antagonistic effects of immunomodulatory drugs on the action of antifungals against Tome M; Zupan J; Tomičić Z; Matos T; Raspor P PeerJ; 2018; 6():e4999. PubMed ID: 29915703 [TBL] [Abstract][Full Text] [Related]
3. Jjj1 Is a Negative Regulator of Pdr1-Mediated Fluconazole Resistance in Whaley SG; Caudle KE; Simonicova L; Zhang Q; Moye-Rowley WS; Rogers PD mSphere; 2018; 3(1):. PubMed ID: 29507891 [TBL] [Abstract][Full Text] [Related]
4. Effects of calcineurin inhibitors, cyclosporine A and tacrolimus (FK506), on the activity of antifungal drugs against Şen Kaya S; Kiraz N; Bariş A; Turan D; Öz Y; Dağ İ; Aygün G J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33915075 [No Abstract] [Full Text] [Related]
5. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates. Denardi LB; Mario DA; Loreto ÉS; Santurio JM; Alves SH Braz J Microbiol; 2015 Mar; 46(1):125-9. PubMed ID: 26221097 [TBL] [Abstract][Full Text] [Related]
6. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species. Nagayoshi Y; Miyazaki T; Shimamura S; Nakayama H; Minematsu A; Yamauchi S; Takazono T; Nakamura S; Yanagihara K; Kohno S; Mukae H; Izumikawa K PLoS One; 2017; 12(7):e0180990. PubMed ID: 28700656 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750 [TBL] [Abstract][Full Text] [Related]
8. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Vermitsky JP; Edlind TD Antimicrob Agents Chemother; 2004 Oct; 48(10):3773-81. PubMed ID: 15388433 [TBL] [Abstract][Full Text] [Related]
9. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759 [TBL] [Abstract][Full Text] [Related]
10. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875 [TBL] [Abstract][Full Text] [Related]
12. Antifungal drug resistance in pathogenic fungi. Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500 [TBL] [Abstract][Full Text] [Related]
13. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142 [TBL] [Abstract][Full Text] [Related]
14. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Sanglard D; Coste AT Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310 [TBL] [Abstract][Full Text] [Related]
15. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery. Keniya MV; Ruma YN; Tyndall JDA; Monk BC Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959 [TBL] [Abstract][Full Text] [Related]
16. In Vitro Characterization of Twenty-One Antifungal Combinations against Echinocandin-Resistant and -Susceptible Khalifa HO; Majima H; Watanabe A; Kamei K J Fungi (Basel); 2021 Feb; 7(2):. PubMed ID: 33540778 [TBL] [Abstract][Full Text] [Related]
17. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains. Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006 [TBL] [Abstract][Full Text] [Related]
18. Multicenter Collaborative Study of the Interaction of Antifungal Combinations against Meletiadis J; Andes DR; Lockhart SR; Ghannoum MA; Knapp CC; Ostrosky-Zeichner L; Pfaller MA; Chaturvedi V; Walsh TJ J Fungi (Basel); 2022 Sep; 8(9):. PubMed ID: 36135692 [TBL] [Abstract][Full Text] [Related]
19. Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata. Whaley SG; Zhang Q; Caudle KE; Rogers PD Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30038038 [TBL] [Abstract][Full Text] [Related]